AHRQ Comparative Research Agenda Due June 8; HHS Priorities Will Be Key
Executive Summary
The Agency for Healthcare Research & Quality plans to meet with senior HHS officials and other stakeholders to assist the agency in developing a cost-effectiveness research agenda by June 8
You may also be interested in...
AHRQ Drug Effectiveness Comparisons Will Focus On 10 “Priority Conditions”
Prescription drug comparative effectiveness research will proceed for 10 "priority conditions," thanks to $15 mil. provided by the fiscal year 2005 omnibus appropriations bill, the Agency for Healthcare Research & Quality said Dec. 15
AHRQ Drug Effectiveness Comparisons Will Focus On 10 “Priority Conditions”
Prescription drug comparative effectiveness research will proceed for 10 "priority conditions," thanks to $15 mil. provided by the fiscal year 2005 omnibus appropriations bill, the Agency for Healthcare Research & Quality said Dec. 15
FDA Mission Should Not Include Rx Cost-Effectiveness, Rep. Allen Says
FDA is not the appropriate agency to oversee comparative research involving drugs and devices, Rep. Tom Allen (D-Maine) says